Interleukin-1β stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells

Peritoneal Dialysis International

Volumn 19, Issue 3, 1999, Pages 211-220

  Yang, Won Seok ^a   Kim, Byung Sik ^a   Lee, Sang Koo ^a   Park, Jung Sik ^a   Kim, Soon Bae ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Fibroblastoid morphology; Fibronectin; Human peritoneal mesothelial cells; Interleukin 1 ; Type I collagen

Indexed keywords

COLLAGEN TYPE 1; CYTOKERATIN; FIBRONECTIN; INTERLEUKIN 1BETA; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1; INTERLEUKIN 1; KERATIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL SHAPE; CELL STRUCTURE; CELL SURFACE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CYTOPLASM; DIALYSATE; DOSE TIME EFFECT RELATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MESOTHELIUM CELL; MESSENGER RNA SYNTHESIS; NORTHERN BLOTTING; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; CYTOLOGY; DOSE RESPONSE; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERLEUKIN-1; KERATINS; PERITONEUM; PROCOLLAGEN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033238014     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900306     Document Type: Article

References (20)

1. Gokal R. Peritoneal infections, hernias and related complications. In: Jacob C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of renal function by dialysis. 4th ed. London: Kluwer Academic, 1996:657-87.
2. Chaimovitz C. Peritoneal dialysis. Kidney Int 1994; 45:1226-40.
3. Bargman JM. Noninfectious complications of peritoneal dialysis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. 1st ed. London: Kluwer Academic, 1994:555-90.
4. Pronk A, Leguit P, Hoynck van Papendrecht AA, Hagelen E, van Vroonhoven TJ, Verbrugh HA. A cobble-stone cell isolated from the human omentum: the mesothelial cell; isolation, identification, and growth characteristics. In Vitro Cell Dev Biol 1993; 29A: 127-34.
5. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37:1563-70.
6. Perfumo F, Altieri P, Degl'Innocenti ML, Ghiggeri GM, Caridi G, Trivelli A, et al. Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation. Nephrol Dial Transplant 1996; 11:1803-9.
7. Postlethwaite AE, Raghow R, Stricklin GP, Poppleton H, Seyer JM, Kang AH. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol 1988; 106:311-18.
8. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S. Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1987; 1:14-16.
9. Shaldon S, Koch K, Quellhorst E, Dinarello CA. Pathogenesis of sclerosing peritonitis in CAPD. ASAIO Trans 1984; 30:193-4.
10. Brauner A, Hylander B, Wreylind B. Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 27:402-8.
11. Bernard MP, Chu ML, Myers JC, Ramirez F, Eikenberry EF, Prockop DJ. Nucleotide sequences of complementary deoxyribonucleic acids for the pro-alpha 1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution. Biochemistry 1983; 22:5213-23.
12. Tokunaka K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47:5616-19.
13. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 1980; 104:205-14.
14. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, et al. Transforming growth factor-β synthesis by human peritoneal mesothelial cells. Am J Pathol 1996; 148:1679-88.
15. Lamperi S, Carozzi S, Nasini MG. Calcium antagonists improve ultrafiltration in patients on continuous ambulatory peritoneal dialysis (CAPD). ASAIO Trans 1987; 33:657-63.
16. Snitkoff G, Bailie GR, Eisele G. Interleukin, endotoxin, and tumor necrosis factor in CAPD dialysate. Perit Dial Int 1995; 15:279-80.
17. Brulez HF, Dekker HA, Oe PL, Verbeelen D, ter Wee PM, Verbrugh HA. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid. Nephron 1996; 74:26-32.
18. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995; 15:158-64.
19. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosis peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12:14-27.
20. Davila RM, Crouch EC. Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 1993; 142:547-55.